Host-Microbiota Interactions in the Pathogenesis of Antibiotic-Associated Diseases

Cell Reports

Volumn 14, Issue 5, 2016, Pages 1049-1061

  Lichtman, Joshua S ^a   Ferreyra, Jessica A ^a   Ng, Katharine M ^a   Smits, Samuel A ^a   Sonnenburg, Justin L ^a   Elias, Joshua E ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; PROTEOME; RNA 16S; STREPTOMYCIN; ANTIINFECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL COLONIZATION; BACTERIAL LOAD; CLOSTRIDIUM DIFFICILE INFECTION; COLITIS; CONTROLLED STUDY; DIGESTIVE SYSTEM INFLAMMATION; DYSBIOSIS; FECAL MICROBIOTA TRANSPLANTATION; FECES ANALYSIS; HOST; IMMUNE RESPONSE; INTESTINE FLORA; MALE; MICROBIAL COMMUNITY; MOUSE; NONHUMAN; PATHOGENESIS; PEPTOCLOSTRIDIUM DIFFICILE; PRIORITY JOURNAL; PROTEOMICS; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; SALMONELLOSIS; SINGLE DRUG DOSE; ANIMAL; DISEASES; FECES; FEMALE; HOST PATHOGEN INTERACTION; INFLAMMATION; MICROBIOLOGY; MICROFLORA; PATHOLOGY;

ANIMALS; ANTI-BACTERIAL AGENTS; DISEASE; FECAL MICROBIOTA TRANSPLANTATION; FECES; FEMALE; HOST-PATHOGEN INTERACTIONS; INFLAMMATION; MALE; MICE; MICROBIOTA; PROTEOME;

EID: 84957935234     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2016.01.009     Document Type: Article

References (41)

1. Abreu M.T. Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat. Rev. Immunol. 2010, 10:131-144.
2. Anders S., Huber W. Differential expression analysis for sequence count data. Genome Biol. 2010, 11:R106.
3. Angelini G., Cavallini G., Bovo P., Brocco G., Castagnini A., Lavarini E., Merigo F., Tallon N., Scuro L.A. Pancreatic function in chronic inflammatory bowel disease. Int. J. Pancreatol. 1988, 3:185-193.
4. Aronesty E. Comparison of sequencing utility programs. Open Bioinform. J. 2013, 7:1-8.
5. Bergogne-Bérézin E. Treatment and prevention of antibiotic associated diarrhea. Int. J. Antimicrob. Agents 2000, 16:521-526.
6. Brandt L.J., Aroniadis O.C., Mellow M., Kanatzar A., Kelly C., Park T., Stollman N., Rohlke F., Surawicz C. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am. J. Gastroenterol. 2012, 107:1079-1087.
7. Brown C.T., Davis-Richardson A.G., Giongo A., Gano K.A., Crabb D.B., Mukherjee N., Casella G., Drew J.C., Ilonen J., Knip M., et al. Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS ONE 2011, 6:e25792.
8. Buffie C.G., Jarchum I., Equinda M., Lipuma L., Gobourne A., Viale A., Ubeda C., Xavier J., Pamer E.G. Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis. Infect. Immun. 2012, 80:62-73.
9. Caporaso J.G., Kuczynski J., Stombaugh J., Bittinger K., Bushman F.D., Costello E.K., Fierer N., Peña A.G., Goodrich J.K., Gordon J.I., et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 2010, 7:335-336.
10. Caporaso J.G., Lauber C.L., Walters W.A., Berg-Lyons D., Lozupone C.A., Turnbaugh P.J., Fierer N., Knight R. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc. Natl. Acad. Sci. USA 2011, 108(Suppl 1):4516-4522.
11. Cash H.L., Whitham C.V., Behrendt C.L., Hooper L.V. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 2006, 313:1126-1130.
12. Choi H., Fermin D., Nesvizhskii A.I. Significance analysis of spectral count data in label-free shotgun proteomics. Mol. Cell. Proteomics 2008, 7:2373-2385.
13. Cooper H.S., Murthy S.N., Shah R.S., Sedergran D.J. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab. Invest. 1993, 69:238-249.
14. Costello E.K., Lauber C.L., Hamady M., Fierer N., Gordon J.I., Knight R. Bacterial community variation in human body habitats across space and time. Science 2009, 326:1694-1697.
15. Cox M.P., Peterson D.A., Biggs P.J. SolexaQA: At-a-glance quality assessment of Illumina second-generation sequencing data. BMC Bioinformatics 2010, 11:485.
16. de Goffau M.C., Luopajärvi K., Knip M., Ilonen J., Ruohtula T., Härkönen T., Orivuori L., Hakala S., Welling G.W., Harmsen H.J., Vaarala O. Fecal microbiota composition differs between children with β-cell autoimmunity and those without. Diabetes 2013, 62:1238-1244.
17. De Nardo D., Labzin L.I., Kono H., Seki R., Schmidt S.V., Beyer M., Xu D., Zimmer S., Lahrmann C., Schildberg F.A., et al. High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3. Nat. Immunol. 2014, 15:152-160.
18. Dethlefsen L., Relman D.A. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc. Natl. Acad. Sci. USA 2011, 108(Suppl 1):4554-4561.
19. Elias J.E., Gygi S.P. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat. Methods 2007, 4:207-214.
20. Eng J.K., McCormack A.L., Yates J.R. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J. Am. Soc. Mass Spectrom. 1994, 5:976-989.
21. Harwig S.S., Tan L., Qu X.D., Cho Y., Eisenhauer P.B., Lehrer R.I. Bactericidal properties of murine intestinal phospholipase A2. J. Clin. Invest. 1995, 95:603-610.
22. Högenauer C., Hammer H.F., Krejs G.J., Reisinger E.C. Mechanisms and management of antibiotic-associated diarrhea. Clin. Infect. Dis. 1998, 27:702-710.
23. Huang W., Sherman B.T., Lempicki R.A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009, 37:1-13.
24. Huang W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4:44-57.
25. Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., Beausoleil S.A., Villén J., Haas W., Sowa M.E., Gygi S.P. A tissue-specific atlas of mouse protein phosphorylation and expression. Cell 2010, 143:1174-1189.
26. Kufer T.A., Banks D.J., Philpott D.J. Innate immune sensing of microbes by Nod proteins. Ann. N Y Acad. Sci. 2006, 1072:19-27.
27. Lawley T.D., Clare S., Walker A.W., Stares M.D., Connor T.R., Raisen C., Goulding D., Rad R., Schreiber F., Brandt C., et al. Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog. 2012, 8:e1002995.
28. Lichtman J.S., Marcobal A., Sonnenburg J.L., Elias J.E. Host-centric proteomics of stool: a novel strategy focused on intestinal responses to the gut microbiota. Mol. Cell. Proteomics 2013, 12:3310-3318.
29. Lichtman J.S., Sonnenburg J.L., Elias J.E. Monitoring host responses to the gut microbiota. ISME J. 2015, 9:1908-1915.
30. Macdonald T.T., Monteleone G. Immunity, inflammation, and allergy in the gut. Science 2005, 307:1920-1925.
31. Martens E.C., Chiang H.C., Gordon J.I. Mucosal glycan foraging enhances fitness and transmission of a saccharolytic human gut bacterial symbiont. Cell Host Microbe 2008, 4:447-457.
32. Nam H.J., Kang J.K., Kim S.-K., Ahn K.J., Seok H., Park S.J., Chang J.S., Pothoulakis C., Lamont J.T., Kim H. Clostridium difficile toxin A decreases acetylation of tubulin, leading to microtubule depolymerization through activation of histone deacetylase 6, and this mediates acute inflammation. J. Biol. Chem. 2010, 285:32888-32896.
33. Ng K.M., Ferreyra J.A., Higginbottom S.K., Lynch J.B., Kashyap P.C., Gopinath S., Naidu N., Choudhury B., Weimer B.C., Monack D.M., Sonnenburg J.L. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature 2013, 502:96-99.
34. Ohl M.E., Miller S.I. Salmonella: a model for bacterial pathogenesis. Annu. Rev. Med. 2001, 52:259-274.
35. Sekirov I., Tam N.M., Jogova M., Robertson M.L., Li Y., Lupp C., Finlay B.B. Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection. Infect. Immun. 2008, 76:4726-4736.
36. Stecher B., Robbiani R., Walker A.W., Westendorf A.M., Barthel M., Kremer M., Chaffron S., Macpherson A.J., Buer J., Parkhill J., et al. Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol. 2007, 5:2177-2189.
37. Sun J., Furio L., Mecheri R., van der Does A.M., Lundeberg E., Saveanu L., Chen Y., van Endert P., Agerberth B., Diana J. Pancreatic β-cells limit autoimmune diabetes via an immunoregulatory antimicrobial peptide expressed under the influence of the gut microbiota. Immunity 2015, 43:304-317.
38. Suzuki K., Fagarasan S. How host-bacterial interactions lead to IgA synthesis in the gut. Trends Immunol. 2008, 29:523-531.
39. Tsuji Y., Watanabe T., Kudo M., Arai H., Strober W., Chiba T. Sensing of commensal organisms by the intracellular sensor NOD1 mediates experimental pancreatitis. Immunity 2012, 37:326-338.
40. Vizcaíno J.A., Côté R.G., Csordas A., Dianes J.A., Fabregat A., Foster J.M., Griss J., Alpi E., Birim M., Contell J., et al. The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013. Nucleic Acids Res. 2013, 41:D1063-D1069.
41. Walker N.I., Bennett R.E., Axelsen R.A. Melanosis coli. A consequence of anthraquinone-induced apoptosis of colonic epithelial cells. Am. J. Pathol. 1988, 131:465-476.